Correction to: Genetics in Medicine 2020; https://doi.org/10.1038/s41436-020-00968-z; published online 30 September 2020
This Article was originally published under Nature Research’s License to Publish, but has now been made available under a [CC BY-NC-ND 4.0] license. The PDF and HTML versions of the Article have been modified accordingly.
Author information
Authors and Affiliations
Corresponding author
Additional information
Author working as a consultant under the contract of Pharmaland Consulting Group.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Bichet, D.G., Aerts, J.M., Auray-Blais, C. et al. Correction: Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease. Genet Med 23, 238 (2021). https://doi.org/10.1038/s41436-020-01041-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41436-020-01041-5
